Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Mater Sci Mater Med ; 28(11): 172, 2017 Sep 27.
Article in English | MEDLINE | ID: mdl-28956202

ABSTRACT

Trilayered polypyrrole (PPy) actuators have high stress density, low modulus and have wide potential biological applications including use in artificial muscles and in limb prosthesis after limb amputation. This article examines the in vivo biocompatibility of actuators in muscle using rabbit models. The actuators were specially designed with pores to encourage tissue in growth; this study also assessed the effect of such pores on the stability of the actuators in vivo. Trilayered PPy actuators were either laser cut with 150 µm pores or left pore-less and implanted into rabbit muscle for 3 days, 2 weeks, 4 weeks and 8 weeks and retrieved subsequently for histological analysis. In a second set of experiments, the cut edges of pores in porous actuator strips were further sealed by PPy after laser cutting to further improve its stability in vivo. Porous actuators with and without PPy sealing of pore edges were implanted intramuscularly for 4 and 8 weeks and assessed with histology. Pore-less actuators incited a mild inflammatory response, becoming progressively walled off by a thin layer of fibrous tissue. Porous actuators showed increased PPy fragmentation and delamination with associated greater foreign body response compared to pore-less actuators. The PPy fragmentation was minimized when the pore edges were sealed off by PPy after laser cutting showing less PPy debris. Laser cutting of the actuators with pores destabilizes the PPy. This can be overcome by sealing the cut edges of the pores with PPy after laser. The findings in this article have implications in future design and manufacturing of PPy actuator for use in vivo.


Subject(s)
Artificial Limbs , Biocompatible Materials/chemistry , Coated Materials, Biocompatible/chemistry , Polymers/chemistry , Prostheses and Implants , Pyrroles/chemistry , Amputation, Surgical/rehabilitation , Animals , Coated Materials, Biocompatible/chemical synthesis , Coated Materials, Biocompatible/pharmacology , Materials Testing , Polymers/pharmacology , Porosity , Prosthesis Implantation , Pyrroles/pharmacology , Rabbits
2.
Dev Neurobiol ; 76(5): 551-65, 2016 May.
Article in English | MEDLINE | ID: mdl-26251299

ABSTRACT

Clustering of acetylcholine receptors (AChR) at the postsynaptic membrane is a crucial step in the development of neuromuscular junctions (NMJ). During development and after denervation, aneural AChR clusters form on the sarcolemma. Recent studies suggest that these receptors are critical for guiding and initiating synaptogenesis. The aim of this study is to investigate the effect of agrin and laminin-1; agents with known AChR clustering activity; on NMJ formation and muscle maturation. Primary myoblasts were differentiated in vitro on collagen, laminin or collagen and laminin-coated surfaces in the presence or absence of agrin and laminin. The pretreated cells were then subject to innervation by PC12 cells. The number of neuromuscular junctions was assessed by immunocytochemical co-localization of AChR clusters and the presynaptic marker synaptophysin. Functional neuromuscular junctions were quantitated by analysis of the level of spontaneous as well as neuromuscular blocker responsive contractile activity and muscle maturation was assessed by the degree of myotube striation. Agrin alone did not prime muscle for innervation while a combination of agrin and laminin pretreatment increased the number of neuromuscular junctions formed and enhanced acetylcholine based neurotransmission and myotube striation. This study has direct clinical relevance for treatment of denervation injuries and creating functional neuromuscular constructs for muscle tissue repair.


Subject(s)
Agrin/metabolism , Laminin/metabolism , Neuromuscular Junction/growth & development , Neuromuscular Junction/metabolism , Receptors, Cholinergic/metabolism , Agrin/administration & dosage , Animals , Cell Differentiation/physiology , Cells, Cultured , Coculture Techniques , Culture Media , Laminin/administration & dosage , Mice, Inbred C57BL , Muscle Contraction/physiology , Muscle Fibers, Skeletal/metabolism , Muscle Fibers, Skeletal/ultrastructure , Myoblasts/metabolism , Myoblasts/ultrastructure , Neuromuscular Junction/ultrastructure , PC12 Cells , Rats
3.
Int J Mol Sci ; 15(7): 11878-921, 2014 Jul 04.
Article in English | MEDLINE | ID: mdl-25000263

ABSTRACT

Joint replacement is a major orthopaedic procedure used to treat joint osteoarthritis. Aseptic loosening and infection are the two most significant causes of prosthetic implant failure. The ideal implant should be able to promote osteointegration, deter bacterial adhesion and minimize prosthetic infection. Recent developments in material science and cell biology have seen the development of new orthopaedic implant coatings to address these issues. Coatings consisting of bioceramics, extracellular matrix proteins, biological peptides or growth factors impart bioactivity and biocompatibility to the metallic surface of conventional orthopaedic prosthesis that promote bone ingrowth and differentiation of stem cells into osteoblasts leading to enhanced osteointegration of the implant. Furthermore, coatings such as silver, nitric oxide, antibiotics, antiseptics and antimicrobial peptides with anti-microbial properties have also been developed, which show promise in reducing bacterial adhesion and prosthetic infections. This review summarizes some of the recent developments in coatings for orthopaedic implants.


Subject(s)
Coated Materials, Biocompatible/chemistry , Joint Prosthesis , Animals , Ceramics/chemistry , Extracellular Matrix Proteins/chemistry , Humans
4.
Int J Artif Organs ; 37(4): 277-91, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24811182

ABSTRACT

Nerve injury secondary to trauma, neurological disease or tumor excision presents a challenge for surgical reconstruction. Current practice for nerve repair involves autologous nerve transplantation, which is associated with significant donor-site morbidity and other complications. Previously artificial nerve conduits made from polycaprolactone, polyglycolic acid and collagen were approved by the FDA (USA) for nerve repair. More recently, there have been significant advances in nerve conduit design that better address the requirements of nerve regrowth. Innovations in materials science, nanotechnology, and biology open the way for the synthesis of new generation nerve repair conduits that address issues currently faced in nerve repair and regeneration. This review discusses recent innovations in this area, including the use of nanotechnology to improve the design of nerve conduits and to enhance nerve regeneration.


Subject(s)
Guided Tissue Regeneration/methods , Nerve Regeneration , Nervous System Diseases/surgery , Regenerative Medicine/methods , Tissue Engineering/methods , Animals , Biocompatible Materials , Genetic Therapy , Humans , Nanomedicine , Nervous System Diseases/genetics , Nervous System Diseases/pathology , Nervous System Diseases/physiopathology , Stem Cell Transplantation , Tissue Scaffolds , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...